Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC.

被引：0
|
作者：
Kim, Sunhee S. [1 ]
Nakakura, Eric K. [1 ]
Wang, Zhen J. [1 ]
Kim, Grace E. [1 ]
Corvera, Carlos U. [1 ]
Harris, Hobart W. [1 ]
Kirkwood, Kimberly S. [1 ]
Hirose, Ryutaro [1 ]
Tempero, Margaret A. [1 ]
Ko, Andrew H. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.351
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
351
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Is Preoperative Chemoradiation Necessary for Borderline Resectable Pancreatic Cancer (BRPC)?: Clinical and Surgical Outcomes Associated with Neoadjuvant FOLFIRINOX Alone in BRPC
    Kim, S. S.
    Ko, A. H.
    Wang, Z. J.
    Kim, G. E.
    Corvera, C. U.
    Harris, H. W.
    Kirkwood, K. S.
    Hirose, R.
    Tempero, M. A.
    Nakakura, E. K.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S165 - S165
  • [2] Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).
    Beg, M. S.
    Olowokure, O. O.
    Ali, S.
    Ahmad, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer (BRPC).
    Tran, Nguyen H.
    Sahai, Vaibhav
    Griffith, Kent A.
    Nathan, Hari
    Kaza, Ravi
    Cuneo, Kyle Clifford
    Sonnenday, Christopher J.
    Cho, Clifford
    Lawrence, Theodore Steven
    Zalupski, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC): Is preoperative chemoradiation (CRT) essential?
    Picozzi, Vincent J.
    Rocha, Flavio G.
    Rose, J. Bart
    Traverso, L. William
    Alseidi, Adnan
    Lin, Bruce S.
    Biehl, Thomas A.
    Ryan, John A.
    Moonka, Ravi
    Helton, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Comment on "Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)''
    Wei, Lee-Jen
    McCaw, Zachary R.
    Tian, Lu
    Kim, Dae Hyun
    ANNALS OF SURGERY, 2019, 270 (02) : E48 - E50
  • [6] Clinical outcomes in borderline resectable pancreatic cancer (BRPC): A single institutional analysis.
    Ezekwudo, Daniel
    Gbadamosi, Bolanle
    Khoury, John
    Blankenship, Leann
    Gaikazian, Susanna S.
    Anderson, Joseph M.
    Stender, Michael J.
    Jury, Robert P.
    Nadeau, Laura
    Matthew, Cotant
    Robertson, John M.
    Margolis, Jeffrey H.
    Jaiyesimi, Ishmael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC)
    Rose, J. Bart
    Rocha, Flavio G.
    Lin, Bruce S.
    Alseidi, Adnan
    Biehl, Thomas A.
    Moonka, Ravi
    Ryan, John A.
    Traverso, L. William
    Helton, Scott
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreatic cancer (BRPC): Updated results.
    Kanji, Zaheer S.
    Rocha, Flavio G.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Lin, Bruce S.
    Kozarek, Richard A.
    Rose, J. Bart B.
    Biehl, Thomas R.
    Alseidi, Adnan
    Helton, Scott
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44
    Lambert, A.
    Bouche, O.
    Ayav, A.
    Bachet, J-B.
    Schwarz, L.
    Piessen, G.
    Vendrely, V.
    Laurent, V.
    Thibaudeau, E.
    Miglianico, L.
    Rinaldi, Y.
    Hammel, P.
    Conroy, T.
    ANNALS OF ONCOLOGY, 2024, 35 : 1252 - 1252
  • [10] Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
    Blazer, Marlo
    Wu, Christina
    Goldberg, Richard M.
    Phillips, Gary
    Schmidt, Carl
    Muscarella, Peter
    Wuthrick, Evan
    Williams, Terrence M.
    Reardon, Joshua
    Ellison, E. Christopher
    Bloomston, Mark
    Bekaii-Saab, Tanios
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (04) : 1153 - 1159
12345